Author
U. P. Neumann
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2016-2023 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 22 mutual co-author links6 papers
Recent·Most cited
- ImmunologybioRxivPreprint
Single-cell immune multi-omics and repertoire analyses in pancreatic ductal adenocarcinoma reveal differential immunosuppressive mechanisms within different tumour microenvironments
S. Sivakumar, A. Jainarayanan, E. Arbe-Barnes…·R. J. M. Bashford-Rogers
The paper analyzes single-cell immune multi-omics data from PDAC to identify differential immunosuppressive mechanisms in distinct tumour microenvironments.
- Cancer BiologybioRxiv
Uncovering novel roles of miR-122 in the pathophysiology of the liver: Potential interaction with NRF1 and E2F4 signaling
M. Paluschinski, J. Schira-Heinen, R. Pellegrino…·M. Castoldi
This study identifies miR-122's role in liver disease by showing its antagonistic effects on NRF1 and E2F4 and its impact on proteins linked to malignancy.
DOI 10.3390/cancers15164129 - Cancer BiologybioRxivPreprint
Nerve fibers in the Tumor Microenvironment are co-localized with Tertiary Lymphoid Structures
L. R. Heij, X. Tan, J. N. Kather…·U. P. Neumann
The paper analyzes nerve fiber density and tertiary lymphoid structures in pancreatic cancer, finding that high nerve fiber density and TLS count correlate with improved survival.
- Cancer BiologybioRxivPreprint
Enhanced inflammatory response mediated by parenchymal cells associates with resistance towards mTOR inhibition
L. Jiao, R. Eickhoff, S. Jumpertz…·T. Cramer
This study shows that mTOR inhibition in liver epithelial cells enhances inflammation and accelerates liver metastases, suggesting non-malignant cells contribute to resistance against mTOR inhibitors.
DOI 10.1101/2020.08.06.239426 - Cancer BiologybioRxiv
Rapid identification of optimal drug combinations for personalized cancer therapy using microfluidics
F. Eduati, R. Utharala, D. Madhavan…·C. A. Merten
This paper presents a microfluidics-based method to rapidly screen drug combinations on patient cancer cells, identifying personalized treatment options validated in pancreatic cancer cell lines.
DOI 10.1038/s41467-018-04919-w